Safety of Covid-19 vaccination in pregnancy | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Funder
The Research Council of Norway (RCN)
Principal Investigator
N/A
Research Location
Norway
Lead Research Institution
Folkehelseinstituttet
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Pregnant women
Occupations of Interest
Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

COVID-19 vaccination around the time of conception and risk of placenta-mediated adverse pregnancy outcomes.

COVID-19 vaccination during pregnancy is not associated with an increased risk of severe postpartum hemorrhage.

Pregnancy, fetal, and neonatal outcomes after a first booster dose of covid-19 vaccine during pregnancy in Ontario, Canada: population based, retrospective cohort study.

Association between SARS-CoV-2 infection and newly diagnosed hypertension during pregnancy: prospective, population based cohort study.

Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark.

Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.